{
"info": {
"nct_id": "NCT00322920",
"official_title": "A Phase I Study of Weekly Topotecan With Cisplatin for the Management of Advanced Stage or Recurrent Carcinoma of the Cervix",
"inclusion_criteria": "* Patients must have persistent, recurrent, or primary Stage IVB carcinoma of the cervix not amenable to curative therapy with either surgery and/or radiation.\n* Patients must have biopsy proven squamous cell, adenosquamous, or adenocarcinoma histology.\n* Patients do not require measurable disease.\n* Patients must have adequate organ function defined by laboratory work.\n* Patients must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.\n* Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy. A minimum of six weeks shall have passed since the last administration of chemoradiotherapy or three weeks for radiation therapy alone.\n* Patients must be free of clinically significant infections.\n* Patients must be age 19 or greater and have signed informed consent.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 19 Years",
"exclusion_criteria": "* Patients who are pregnant or lactating.\n* Patients with history of other malignancies (except non-melanoma skin cancer) within the last 5 years are ineligible.\n* Patients with non-squamous, adenosquamous, or adenocarcinoma histology.\n* Patients with bilateral hydronephrosis that cannot be alleviated by ureteral stents or percutaneous drainage.\n* Patients currently receiving any or having received other investigational agents within the last 30 days are ineligible.\n* Patients with known hypersensitivity to topotecan or cisplatin.\n* Patients with craniospinal metastases.\n* Patients with uncontrolled current illness including, but not limited to, ongoing or active infection, unstable angina pectoris, cardiac arrhythmia, serious peripheral neuropathy, or psychiatric illness/social situations that would limit or preclude compliance with study requirements are ineligible.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients must have persistent, recurrent, or primary Stage IVB carcinoma of the cervix not amenable to curative therapy with either surgery and/or radiation.",
"criterions": [
{
"exact_snippets": "persistent, recurrent, or primary Stage IVB carcinoma of the cervix",
"criterion": "carcinoma of the cervix",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "IVB"
},
{
"requirement_type": "persistence",
"expected_value": true
},
{
"requirement_type": "recurrence",
"expected_value": true
},
{
"requirement_type": "primary",
"expected_value": true
}
]
},
{
"exact_snippets": "not amenable to curative therapy with either surgery and/or radiation",
"criterion": "amenability to curative therapy",
"requirements": [
{
"requirement_type": "amenability",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must have biopsy proven squamous cell, adenosquamous, or adenocarcinoma histology.",
"criterions": [
{
"exact_snippets": "biopsy proven squamous cell",
"criterion": "squamous cell histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "biopsy proven ... adenosquamous",
"criterion": "adenosquamous histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "biopsy proven ... adenocarcinoma histology",
"criterion": "adenocarcinoma histology",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients do not require measurable disease.",
"criterions": [
{
"exact_snippets": "do not require measurable disease",
"criterion": "measurable disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must have adequate organ function defined by laboratory work.",
"criterions": [
{
"exact_snippets": "adequate organ function",
"criterion": "organ function",
"requirements": [
{
"requirement_type": "adequacy",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients must have an Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1.",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group (ECOG) Performance Status of 0 or 1",
"criterion": "ECOG Performance Status",
"requirements": [
{
"requirement_type": "value",
"expected_value": [
"0",
"1"
]
}
]
}
]
},
{
"line": "* Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy. A minimum of six weeks shall have passed since the last administration of chemoradiotherapy or three weeks for radiation therapy alone.",
"criterions": [
{
"exact_snippets": "Patients must have recovered from any effects attributable to surgery, radiation, or chemoradiotherapy.",
"criterion": "recovery from treatment effects",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "A minimum of six weeks shall have passed since the last administration of chemoradiotherapy",
"criterion": "time since last chemoradiotherapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 6,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "three weeks for radiation therapy alone",
"criterion": "time since last radiation therapy",
"requirements": [
{
"requirement_type": "time elapsed",
"expected_value": {
"operator": ">=",
"value": 3,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Patients must be free of clinically significant infections.",
"criterions": [
{
"exact_snippets": "free of clinically significant infections",
"criterion": "clinically significant infections",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients must be age 19 or greater and have signed informed consent.",
"criterions": [
{
"exact_snippets": "age 19 or greater",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "years"
}
}
]
},
{
"exact_snippets": "signed informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "signed",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "healthy volunteers",
"requirements": [
{
"requirement_type": "participation",
"expected_value": true
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 19 Years",
"criterions": [
{
"exact_snippets": "minimum age of 19 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 19,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Patients who are pregnant or lactating.",
"criterions": [
{
"exact_snippets": "Patients who are pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with history of other malignancies (except non-melanoma skin cancer) within the last 5 years are ineligible.",
"criterions": [
{
"exact_snippets": "history of other malignancies (except non-melanoma skin cancer) within the last 5 years",
"criterion": "history of other malignancies",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 5,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "* Patients with non-squamous, adenosquamous, or adenocarcinoma histology.",
"criterions": [
{
"exact_snippets": "non-squamous",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "non-squamous"
}
]
},
{
"exact_snippets": "adenosquamous",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "adenosquamous"
}
]
},
{
"exact_snippets": "adenocarcinoma",
"criterion": "histology",
"requirements": [
{
"requirement_type": "type",
"expected_value": "adenocarcinoma"
}
]
}
]
},
{
"line": "* Patients with bilateral hydronephrosis that cannot be alleviated by ureteral stents or percutaneous drainage.",
"criterions": [
{
"exact_snippets": "bilateral hydronephrosis",
"criterion": "bilateral hydronephrosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "cannot be alleviated by ureteral stents",
"criterion": "alleviation by ureteral stents",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
},
{
"exact_snippets": "cannot be alleviated by ... percutaneous drainage",
"criterion": "alleviation by percutaneous drainage",
"requirements": [
{
"requirement_type": "effectiveness",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients currently receiving any or having received other investigational agents within the last 30 days are ineligible.",
"criterions": [
{
"exact_snippets": "Patients currently receiving any or having received other investigational agents within the last 30 days",
"criterion": "investigational agents",
"requirements": [
{
"requirement_type": "receipt",
"expected_value": false
}
]
}
]
},
{
"line": "* Patients with known hypersensitivity to topotecan or cisplatin.",
"criterions": [
{
"exact_snippets": "known hypersensitivity to topotecan",
"criterion": "hypersensitivity to topotecan",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known hypersensitivity to ... cisplatin",
"criterion": "hypersensitivity to cisplatin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with craniospinal metastases.",
"criterions": [
{
"exact_snippets": "craniospinal metastases",
"criterion": "craniospinal metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with uncontrolled current illness including, but not limited to, ongoing or active infection, unstable angina pectoris, cardiac arrhythmia, serious peripheral neuropathy, or psychiatric illness/social situations that would limit or preclude compliance with study requirements are ineligible.",
"criterions": [
{
"exact_snippets": "uncontrolled current illness ... ongoing or active infection",
"criterion": "ongoing or active infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... unstable angina pectoris",
"criterion": "unstable angina pectoris",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... cardiac arrhythmia",
"criterion": "cardiac arrhythmia",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... serious peripheral neuropathy",
"criterion": "serious peripheral neuropathy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "uncontrolled current illness ... psychiatric illness/social situations that would limit or preclude compliance with study requirements",
"criterion": "psychiatric illness/social situations",
"requirements": [
{
"requirement_type": "impact on compliance",
"expected_value": "limit or preclude"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}